Index
Welcome to the Bioloupe Data documentation.
- 0001 Source Derived Disease Biomarker Spine
- 0002 Curated Disease Taxonomy Owns Q Diseases
- 0003 Seed Disease Taxonomy From Legacy Simplified Set
- 0004 Curated Disease Dag Not Ncit Hierarchy
- 0005 Clinical Trials Capability Parity Source First Dag
- 0006 Source Matched Legacy Evidence Salvage
- 0007 Inference Lifecycle And Ownership
- 0008 Development State Is Contextual
- 0009 Separate Deal Events Identity And Rights
- 0010 Versioned Bioloupe Disease Taxonomy
- 0011 Regulatory Approved Use Is Not Standard Of Care
- 0012 Fixtures Are Not Live Parity Evidence
Agents
Section titled “Agents”- 00 Index
- 01 Product Principles
- 02 Product Capability Contract
- 03 Repository Blueprint
- 04 Dagster Asset Graph
- 05 Agentic Curation And Overrides
- 06 Llm Extraction And Verification
- 07 Sql Query Layer
- 08 Contracts And Quality
- 09 Operations Observability
- 10 Testing Strategy
- 11 Legacy Salvage And Backfills
- 12 Source First Ingestion
- 13 Schema Evolution
- 20 Pipeline Families
- 21 Slice Clinical Trials
- 22 Slice Regulatory Approvals
- 23 Slice Publications
- 24 Slice News Intelligence
- 25 Slice Standard Of Care
- 26 Slice Organisation Intelligence
- 27 Slice Discovery Search
- 28 Slice Forecasting Tpp
- 29 Slice Drug Identity
- 30 Slice Disease Biomarker Identity
- 31 Slice Target Technology Identity
- 32 Slice Endpoint Adverse Event Identity
- 33 Slice Development Landscapes
- 34 Slice Epidemiology
- 35 Slice Commercial Intelligence